IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 523.28B
Enterprise Value 324.21B
Trailing P/E 58.32
Forward P/E 148.64
PEG Ratio (5 yr expected) 12.95
Price/Sales (ttm)10.16
Price/Book (mrq)135.97
Enterprise Value/Revenue 310.57
Enterprise Value/EBITDA 639.22

Trading Information

Stock Price History

Beta (3Y Monthly) 1.22
52-Week Change 311.36%
S&P500 52-Week Change 30.90%
52 Week High 3292.17
52 Week Low 3176.11
50-Day Moving Average 3279.19
200-Day Moving Average 3246.16

Share Statistics

Avg Vol (3 month) 3372.29k
Avg Vol (10 day) 3313.4k
Shares Outstanding 586.09M
Float 84.74M
% Held by Insiders 11.60%
% Held by Institutions 190.89%
Shares Short (Jul 31, 2019) 41.22M
Short Ratio (Jul 31, 2019) 43.62
Short % of Float (Jul 31, 2019) 41.61%
Short % of Shares Outstanding (Jul 31, 2019) 41.41%
Shares Short (prior month Jun 28, 2019) 41.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 17.78%
Operating Margin (ttm)23.25%

Management Effectiveness

Return on Assets (ttm)20.52%
Return on Equity (ttm)623.26%

Income Statement

Revenue (ttm)2.29B
Revenue Per Share (ttm)26.52
Quarterly Revenue Growth (yoy)6.80%
Gross Profit (ttm)1.24B
EBITDA 617.2M
Net Income Avi to Common (ttm)407.28M
Diluted EPS (ttm)4.64
Quarterly Earnings Growth (yoy)15.70%

Balance Sheet

Total Cash (mrq)110.84M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)1.04B
Total Debt/Equity (mrq)604.15
Current Ratio (mrq)1.15
Book Value Per Share (mrq)1.99

Cash Flow Statement

Operating Cash Flow (ttm)417.84M
Levered Free Cash Flow (ttm)257.8M